<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Arbutus Biopharma Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      William H. Collier
    • FOUNDED
      1992
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    DirectCare, Inc.

    DirectCare, Inc.

    Kumba Health is an online platform connecting doctors with patients. Kumba Health ...

    Kumba Health is an online platform connecting d...

    Fundraising Status:    SD
    Filing Type:    CF
    Clean Bite, LLC

    Clean Bite, LLC

    Clean Bite is a toothbrush for people who want to brush their teeth whenever situa...

    Clean Bite is a toothbrush for people who want ...

    Amount Raised:    $16,296
    Filing Type:    CF
    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suff...

    Marinus Pharmaceuticals, Inc. is committed to i...

    Filing Type:    PU
    Odonate Therapeutics, Inc.

    Odonate Therapeutics, Inc.

    We are a pharmaceutical company dedicated to the development of best-in-class ther...

    We are a pharmaceutical company dedicated to th...

    Filing Type:    PU
    Ultragenyx Pharmaceutical Inc.

    Ultragenyx Pharmaceutical Inc.

    Ultragenyx is a biopharmaceutical company committed to bringing to patients novel ...

    Ultragenyx is a biopharmaceutical company commi...

    Filing Type:    PU
    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc. is a leading regenerative medicine company focused on ...

    Organogenesis Holdings Inc. is a leading regene...

    Filing Type:    PU
    VBI Vaccines, Inc.

    VBI Vaccines, Inc.

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company d...

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercia...

    Filing Type:    PU
    Spring Bank Pharmaceuticals, Inc.

    Spring Bank Pharmaceuticals, Inc.

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery...

    Spring Bank is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Assembly Biosciences, Inc.

    Assembly Biosciences, Inc.

    Assembly Biosciences is advancing a new class of oral therapeutics for the treatme...

    Assembly Biosciences is advancing a new class o...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.